Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge

摘要

Non-alcoholic steatohepatitis(NASH)is the most common chronic liver disease worldwide,and the fastest growing indication for liver transplantation in the United States.NASH is now the leading etiology for liver transplantation in women,the second leading indication for men,and the most common cause amongst recipients aged 65 years and older.Patients with end-stage liver disease related to NASH represent a unique and challenging patient population due the high incidence of associated comorbid diseases,including obesity,type 2 diabetes(T2D),and hypertension.These challenges manifest in the pre-liver transplantation period with increased waitlist times and waitlist mortality.Furthermore,these patients carry considerable risk of morbidity and mortality both before after liver transplantation,with high rates of T2D,cardiovascular disease,chronic kidney disease,poor nutrition,and disease recurrence.Successful transplantation for these patients requires identification and management of their comorbidities in the face of liver failure.Multidisciplinary evaluations include a thorough pre-transplant workup with a complete cardiac evaluation,control of diabetes,nutritional support,and even,potentially,consultation with a bariatric surgeon.This article provides a comprehensive review of the conditions and challenges facing patients with NASH cirrhosis undergoing liver transplantation and provides recommendations for evaluation and management to optimize them before liver transplantation to produce successful outcomes.